Evidence map›Paper›PMID 26422652›Full record

ReviewJournal of plastic, reconstructive & aesthetic surgery : JPRAS2016

Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier.

Aaron Tan, Reema Chawla, Natasha G, Sara Mahdibeiraghdar, Rebecca Jeyaraj, Jayakumar Rajadas, Michael R Hamblin, Alexander M Seifalian

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Nanotechnology, nanosurfaces and silicone gel breast implants: current aspects.Case reports in plastic surgery & hand surgery · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aaron TanUCL Medical School, University College London (UCL), London, England, UK; Biomaterials & Advanced Drug Delivery Laboratory (BioADD), Stanford University School of Medicine, Stanford University, Stanford, CA, USA. Electronic address: aaron.tan@ucl.ac.uk.
Reema ChawlaDepartment of Plastic & Reconstructive Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, England, UK.
Natasha GUCL Medical School, University College London (UCL), London, England, UK.
Sara MahdibeiraghdarUCL Institute of Child Health, University College London (UCL), Great Ormond Street Hospital for Children NHS Foundation Trust, London, England, UK; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
Rebecca JeyarajUCL Medical School, University College London (UCL), London, England, UK.
Jayakumar RajadasBiomaterials & Advanced Drug Delivery Laboratory (BioADD), Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
Michael R HamblinWellman Centre for Photomedicine, Massachusetts General Hospital, Boston, MA, USA; Department of Dermatology, Harvard Medical School, Boston, MA, USA; Harvard-MIT Division of Health Sciences & Technology, Cambridge, MA, USA.
Alexander M SeifalianCentre for Nanotechnology & Regenerative Medicine, UCL Division of Surgery & Interventional Science, University College London (UCL), London, England, UK; NanoRegMed Ltd, London, England, UK.

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
NIAID NIH HHS R01 AI050875
6 · The paper itself

Abstract

The rapid ascent of nanotechnology and regenerative therapeutics as applied to medicine and surgery has seen an exponential rise in the scale of research generated in this field. This is evidenced not only by the sheer volume of papers dedicated to nanotechnology but also in a large number of new journals dedicated to nanotechnology and regenerative therapeutics specifically to medicine and surgery. Aspects of nanotechnology that have already brought benefits to these areas include advanced drug delivery platforms, molecular imaging and materials engineering for surgical implants. Particular areas of interest include nerve regeneration, burns and wound care, artificial skin with nanoelectronic sensors and head and neck surgery. This study presents a review of nanotechnology and regenerative therapeutics, with focus on its applications and implications in plastic surgery.

Indexed as

BurnsHumansPlastic Surgery ProceduresSurgery, PlasticTheranostic NanomedicineTissue EngineeringCyborg tissueNanoelectronicsNanoengineeringNanotechnologyPlastic surgeryTheranostics

Identifiers

PMID26422652
PMCPMC4703458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.